A Randomized, Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics, Safety and Tolerability of Single Dose of Abatacept 125mg Administered Subcutaneously in Chinese Healthy Subjects
Latest Information Update: 14 Nov 2018
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Jiangsu Simcere Pharmaceutical
- 03 Dec 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 22 Jun 2016 New trial record